Rachel Byrd is a trusted adviser to healthcare clients and investors providing comprehensive guidance on transactions and regulatory compliance. Her practice spans the full lifecycle of deals – from structuring and negotiation to post-closing integration and compliance – while navigating complex healthcare regulations, fraud and abuse laws, and state licensing requirements. Rachel provides strategic solutions for operational and compliance challenges during transactions. She represents a variety of different stakeholders in the healthcare industry, including private equity funds, strategic investors, portfolio companies, and physicians in a broad array of healthcare transactions.
Rachel’s practice includes:
- Private Equity & Strategic Transactions – Representing private equity funds and strategic investors in acquisitions, joint ventures, and physician practice management arrangements. She also advises on deal structuring and execution to maximize value while mitigating regulatory risk.
- Ambulatory Surgery Centers – Advising on ambulatory surgery center (ASC) transactions, including acquisitions, divestitures, joint ventures, physician syndications, and de novo facilities. She offers counsel regarding ASC development, strategy, and compliance.
- Regulatory Compliance and Fraud & Abuse – Offering in-depth guidance on federal and state healthcare regulations impacting transactions and advising on compliance with the Anti-Kickback Statute, Stark Law, and other fraud and abuse laws.
- Medicare, Medicaid & Licensing – Ensuring adherence to corporate practice of medicine prohibitions and state licensing mandates and assisting with enrollment and participation requirements for Medicare and Medicaid programs.
Prior to joining Bass, Berry & Sims, Rachel was a partner at McDermott Will & Schulte in the healthcare group.